Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05794087 · ClinicalTrials.gov registry record · NA

The Role of Macrophage Activation in Lung Injury Following Ozone Exposure

A NA study of Air Pollution, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05794087 is a NA study of Air Pollution that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 120 participants, above the 45-participant average among 7 other Air Pollution trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05794087, a NA study of Air Pollution, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to better understand the mechanisms of lung injury from ozone exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone. The exposure visits will be at least 2 weeks apart. Subjects will be asked to produce sputum through coughing after each exposure. The samples will be analyzed for macrophage activity.

Conditions Studied

Interventions

  • OTHER Clean Air
  • OTHER Ozone

Study Locations (1)

New Jersey

  • Rutgers - EOHSI - Piscataway

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-02-07
Est. Completion 2027-06-01
Phase NA

What the Registry Record Tells You About NCT05794087

The ClinicalTrials.gov registry entry for NCT05794087 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 7 other Air Pollution trials with a reported enrollment target (167% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Air Pollution appearing as the primary indexed condition, and to 2 interventions - of which Clean Air is the first listed.

NCT05794087 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05794087 about?

NCT05794087 is a clinical study titled "The Role of Macrophage Activation in Lung Injury Following Ozone Exposure". The purpose of the study is to better understand the mechanisms of lung injury from ozone exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone. The exposure visits will be at least 2 weeks apart. Subjects will be asked to produce sputum through coughing after ...

What is the current status of trial NCT05794087?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-02-07. Estimated completion is 2027-06-01.

What conditions does trial NCT05794087 study?

This clinical trial studies the following conditions: Air Pollution.

What interventions are being tested in trial NCT05794087?

The interventions under investigation include: Clean Air (OTHER), Ozone (OTHER).

Who is sponsoring clinical trial NCT05794087?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05794087 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Air Pollution

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.